These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16963547)

  • 1. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease.
    Ramsey SD; Hobbs FD
    Proc Am Thorac Soc; 2006 Sep; 3(7):635-40. PubMed ID: 16963547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2007 GOLD Guidelines: a comprehensive care framework.
    Gold PM
    Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and Chronic Obstructive Pulmonary Disease: Treatment Trials.
    Borson S; Claypoole K; McDonald GJ
    Semin Clin Neuropsychiatry; 1998 Apr; 3(2):115-130. PubMed ID: 10085198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we define well-controlled chronic obstructive pulmonary disease?
    Molina París J
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):3-15. PubMed ID: 23551019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease: the disease and its burden to society.
    Halpin DM; Miravitlles M
    Proc Am Thorac Soc; 2006 Sep; 3(7):619-23. PubMed ID: 16963544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated care facilitation model improves quality of life and reduces use of hospital resources by patients with chronic obstructive pulmonary disease and chronic heart failure.
    Bird S; Noronha M; Sinnott H
    Aust J Prim Health; 2010; 16(4):326-33. PubMed ID: 21138701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End stage chronic obstructive pulmonary disease.
    Ambrosino N; Gherardi M; Carpenè N
    Pneumonol Alergol Pol; 2009; 77(2):173-9. PubMed ID: 19462352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease.
    Rennard SI
    Proc Am Thorac Soc; 2005; 2(1):94-100. PubMed ID: 16113475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; Al MJ; Feenstra TL
    Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of chronic obstructive pulmonary disease.
    Ismail TS
    Med J Malaysia; 2009 Sep; 64(3):250-5; quiz 256. PubMed ID: 20527283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multidimensional impact of COPD exacerbations].
    Soler-Cataluña JJ; Martínez-García MÁ; Serra PC
    Arch Bronconeumol; 2010 Dec; 46 Suppl 11():12-9. PubMed ID: 21316556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic obstructive pulmonary disease and its comorbidities.
    Luppi F; Franco F; Beghé B; Fabbri LM
    Proc Am Thorac Soc; 2008 Dec; 5(8):848-56. PubMed ID: 19017740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
    Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J;
    Am J Respir Crit Care Med; 2007 Sep; 176(6):532-55. PubMed ID: 17507545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.